Xerient

Business Data, Corporate Office and Headquarter Address

About

Xerient is Drug Discovery in Israel that focus on operator business. Founded in 2019. They cover business area such as operator, radiation therapy.

Business Type

Drug Discovery

Country

Israel

Founded

2019
( 5 years old in 2024 )

Company Focus

Operator

Website

-

Corporate Office and Headquarter Office address:

Rehov Zichron Yaacov 6
Petah Tikva 4972801
Israel

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

operatorradiation therapy

* We use standard office opening hours in near Xerient's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Xerient Frequently Asked Questions

What or who is Xerient?

Xerient is Drug Discovery business from Israel that founded in 2019 (5 years old in 2024), Xerient business is focusing on Operator.

Where is Xerient headquarter and corporate office address?

Xerient headquarter office and corporate office address is located in Rehov Zichron Yaacov 6 Petah Tikva 4972801 Israel.

Where is Xerient country origins?

Xerient was founded in Israel.

What is Operator business focus on?

In 2024, Xerient is currently focus on operator sector.

Operator Business Interest from Google Trend

Above is snippet of Google Trends for "operator" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with Xerient, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.